Search

New approaches are underway for treating nonalcoholic steatohepatitis.

Vaccine development for COVID-19 may have been rapid, but no one has scrimped on safety.

In this eBook, thought leaders from Cambrex discuss market opportunities, drug development challenges, and more.

Small-molecule Sb9 inhibitor targets both cancer and associated cells to suppress tumor growth in mice.

Biocatalysis is an increasingly attractive option in pharmaceutical synthesis.

Pharma hasn’t always covered itself in glory – but as the world scrambles for viable COVID-19 interventions, it has a rare opportunity to rebrand.

How can we get macromolecules across the intestinal epithelial barrier?

Granulation has been an integral process within pharmaceutical manufacturing for years

Early identification of potential issues within an API’s solid form can accelerate time to market and reduce associated costs.

We Sit Down With Sandy Macrae, Chief Executive Officer, Sangamo Therapeutics, USA.